News About: Pharm. Industry
Dongkook struggles to reverse decline in Insadol sales
Dongkook Pharm has strived to boost the sluggish sales of Insadol, a top-selling OCT medicine for treatment of gingival disease, by providing better wholesaler’s margin.
The company is hoping to find sales-boosting...
Zuellig Korea faces bumpy road over sales
Rough sailing is expected in the sales of Zuellig Korea as wholesalers are showing sign of avoiding medicines supplied by Zullig Korea.
Sources say many wholesalers are reluctant to purchase Zuellig products due to...
Treatment for premature ejaculation to hit market
Korean men with premature ejaculation will be able to prevent premature ejaculation, a distressing sexual dysfunction that can be present from the first sexual encounter or can develop later in life, within this year....
Government urged to promote domestic pharmaceutical industry
Domestic pharmaceutical companies have called on the government to boost the local pharmaceutical industry through the passage of a pharmaceutical promotion act.
A public hearing is scheduled to be held in the midd...
Green Cross signs drug export deal
Green Cross Corporation has signed a contract with an Iranian company to export its newly developed medicine ‘Green Gene’ to cure hemophilia type A.
The first deal in the scale of $4.2 million will pave the way for...
Combined sales of 9 drugmakers surge amid slump
Overall, the nine top pharmaceutical firms – Dong-A Pharm, Yuhan Corporation, Hanmi Pharm, Green Cross Corporation, Chong Kun Dang Pharmaceutical, LG Life Sciences, Handok Pharm, Whanin Pharm and Yungjin Pharm - jumpe...
Wooshin Medix wins patent disputes over risedronate sodium
Wooshin Medix has been making major strides by successfully winning patent disputes on risedronate sodium, which has been imported from Poland based Polpharma Co.
Wooshin is going on step further in securing its ke...
Kim Dong-yeon named to head Ilyang Pharm
Kim Dong-yeon, vice president of Ilyang Pharm, was promoted on May 1 to the post of Ilyang president.
Kim said he would improve competitiveness of the company through reinforcement of its R&D capacity.
“Ilyang i...
Kolon to work with Topimed on anti-skin atrophy drug
Kolon Pharm said that it has agreed with Israel based Topimed LTD, a biopharmaceutical company, to work together in the development of a skin anti-ageing preparation.
Kolon said that it signed a memorandum of under...
Drugmakers urged to set eyes on overseas markets
Korean pharmaceutical firms will have to going all-out to make inroads into three big markets – North America, Europe and Japan – as the domestic market shows clear signs of reaching saturation point.
The nation's ...
